Towards a harmonised EU assessment of the added therapeutic value of medicines
This study, produced for the ENVI Committee by Policy Department A, investigates the possibility of a harmonised EU approach concerning the assessment of the added therapeutic value (ATV) of medicinal products. It reviews the current EU legal and policy framework and looks at the state-of-play within all 28 Member States. In addition, it presents the results of an in-depth analysis on the use of ATV in six selected EU countries. The study closes with policy recommendations on how a possible European harmonisation of the ATV assessment might be taken forward within the current legal framework.
- Corporate author(s): Directorate-General for Internal Policies of the Union Themes: Health policy, Approximation of legislation, Pharmaceutical and cosmetics industry
- Subject: approximation of laws, drugs classification, EU law, EU Member State, medicament, public health, therapeutics, trade licence